Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Corona LifeCare A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   2.6% 4.8% 2.2% 3.1% 2.3% 2.1% 10.0% 9.8%   Credit score (0-100)   63 46 66 55 64 66 25 25   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,617 1,952 2,796 3,544 2,657 2,098 0.0 0.0   EBITDA   532 -126 886 1,607 960 470 0.0 0.0   EBIT   473 -165 861 1,574 949 470 0.0 0.0   Pre-tax profit (PTP)   384.6 -148.8 813.1 1,537.9 901.9 454.1 0.0 0.0   Net earnings   296.9 -120.2 634.1 1,199.3 703.2 354.1 0.0 0.0   Pre-tax profit without non-rec. items   385 -149 813 1,538 902 454 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   108 69.3 44.4 11.1 0.0 0.0 0.0 0.0   Shareholders equity total   1,470 1,350 1,984 2,433 2,586 2,390 1,540 1,540   Interest-bearing liabilities   1,050 417 422 23.4 328 283 0.0 0.0   Balance sheet total (assets)   3,837 3,546 3,956 3,783 3,779 3,632 1,540 1,540   Net Debt   1,035 26.1 -1,814 -1,442 -1,328 -1,534 -1,540 -1,540     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,617 1,952 2,796 3,544 2,657 2,098 0.0 0.0   Gross profit growth   3.1% -46.0% 43.3% 26.8% -25.0% -21.0% -100.0% 0.0%   Employees   6 6 6 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% -50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,837 3,546 3,956 3,783 3,779 3,632 1,540 1,540   Balance sheet change%   -0.4% -7.6% 11.6% -4.4% -0.1% -3.9% -57.6% 0.0%   Added value   531.8 -126.2 886.1 1,607.1 982.6 469.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -118 -78 -50 -67 -22 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.1% -8.5% 30.8% 44.4% 35.7% 22.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.4% -2.2% 23.1% 40.7% 25.1% 12.9% 0.0% 0.0%   ROI %   19.2% -3.8% 41.5% 64.8% 35.4% 17.1% 0.0% 0.0%   ROE %   22.5% -8.5% 38.0% 54.3% 28.0% 14.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   38.3% 38.1% 50.1% 64.3% 68.4% 65.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   194.7% -20.7% -204.7% -89.7% -138.3% -326.5% 0.0% 0.0%   Gearing %   71.5% 30.9% 21.3% 1.0% 12.7% 11.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.8% 9.2% 12.6% 16.6% 27.1% 7.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.5 0.5 1.5 1.7 2.1 1.9 0.0 0.0   Current Ratio   1.6 1.6 2.0 2.8 3.2 2.9 0.0 0.0   Cash and cash equivalent   15.3 390.7 2,235.9 1,464.9 1,655.8 1,816.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,317.2 1,216.0 1,875.1 2,411.6 2,576.0 2,380.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   89 -21 148 536 328 157 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   89 -21 148 536 320 157 0 0   EBIT / employee   79 -28 144 525 316 157 0 0   Net earnings / employee   49 -20 106 400 234 118 0 0